Nectar Lifesciences Limited , a prominent player in the pharmaceutical industry, has announced a significant development regarding its promoters' shareholding. The company disclosed that two of its key promoters, Sanjiv Goyal and Sanjiv HUF, have released a substantial number of pledged shares.

Details of the Pledge Release

The pledge release was executed by SBICAP Trustee Company Limited, acting as the security trustee for the company's lenders.

Impact on Shareholding

It's important to note that this development does not alter the actual ownership of shares by the promoters. Both Sanjiv Goyal and Sanjiv HUF have maintained their respective shareholding percentages. The transaction solely involves the release of previously pledged shares.

Regulatory Compliance

In compliance with the Securities and Exchange Board of India (SEBI) regulations, specifically the Prohibition of Insider Trading Regulations, 2015, Nectar Lifesciences has duly filed the required disclosures. The promoters submitted Form B, detailing the changes in their securities holding, which the company then reported to the stock exchanges.

This move by Nectar Lifesciences' promoters to release a significant portion of their pledged shares may be viewed as a notable development in the company's financial landscape. However, the full impact of this action on the company's future performance remains to be seen.

Nectar Lifesciences Limited , a prominent player in the pharmaceutical industry, has made a significant stride in improving its financial health. The company has announced the complete repayment of its secured debt, along with accrued interest, to its consortium lenders.

Key Highlights

• Debt Repayment: Nectar Lifesciences has fully repaid its secured debt to consortium lenders.
• Amount Settled: The total consortium charge satisfied amounts to INR 1,338.35 crore.
• Assets Released: The repayment releases both movable and immovable assets, including current assets, from the consortium charge.
• Security Trustee: SBICAP Trustee Company Limited acted as the Security Trustee for the lenders.
• Official Registration: The satisfaction of charge has been registered with the Registrar of Companies, Punjab and Chandigarh on October 22, 2025.

Financial Implications

This debt clearance marks a pivotal moment for Nectar Lifesciences, potentially leading to:

1. Improved financial flexibility
2. Enhanced creditworthiness
3. Reduced interest burden
4. Greater operational freedom with unencumbered assets

Regulatory Compliance

The company has duly informed the National Stock Exchange of India Limited and BSE Limited about this development, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Company's Statement

Sanjaymohan Singh Rawat, Company Secretary & Compliance Officer of Nectar Lifesciences Limited, confirmed the development in an official communication to the stock exchanges. The statement emphasized that the satisfaction of charge has been "duly filed and registered on October 22, 2025, with the Registrar of Companies, Punjab and Chandigarh, Ministry of Corporate Affairs, Government of India, in accordance with the provisions of Chapter VI of the Companies Act, 2013."

This strategic move by Nectar Lifesciences to clear its substantial secured debt signifies a strong commitment to financial prudence and may position the company for more robust growth in the coming years. Investors and market watchers will likely keep a close eye on how this debt clearance translates into the company's operational and financial performance in the subsequent quarters.